Physician profile
Carl Lauryssen
NPI 1568410629
$570,581.01
in general payments reported to CMS, 2019-2025
23 companies · $77K in 2025
The $77K reported for 2025 was more than what 97% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $50K · 2021: $263K · 2022: $15K · 2023: $50K · 2024: $61K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $171K · Consulting Fee: $12K · Travel and Lodging: $2,559 · Food and Beverage: $2,255 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $171,189.31 |
| Consulting Fee | $12,068.86 |
| Travel and Lodging | $2,558.93 |
| Food and Beverage | $2,254.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $177.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $219,369.30 | 2021-2025 | Unid_pass, Rialto Si Fusion System |
| Orthofix Medical, INC. | $186,597.35 | 2019-2025 | Meridian, Physio-Stim, Miscellaneous |
| Seaspine Orthopedics Corporation | $57,291.10 | 2019-2022 | |
| Aesculap Implant Systems, LLC | $45,022.88 | 2019-2025 | None |
| Globus Medical, INC. | $27,013.11 | 2019-2025 | Reline |
| Medtronic USA, INC. | $26,021.99 | 2019-2020 | |
| Alphatec Spine, INC | $2,163.75 | 2019-2020 | |
| Providence Medical Technology, INC. | $2,093.14 | 2025 | |
| Spinefrontier, INC. | $1,252.71 | 2019 | |
| Clariance, INC. | $1,237.20 | 2020 | |
| Ctl Medical Corporation | $1,199.60 | 2019-2020 | |
| Nuvasive, INC. | $269.66 | 2019-2022 | |
| Intrinsic Therapeutics | $269.35 | 2024 | Barricaid Acd (Annular Closure Device) |
| Choice Spine, LLC | $253.92 | 2019-2021 | |
| Spineology INC. | $177.30 | 2024 | Optimesh Expandable Interbody Fusion System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $140.46 | 2021 | |
| Si-Bone, INC. | $69.54 | 2019 | |
| Abbott Laboratories | $51.93 | 2023-2025 | Proclaim, Infinity |
| Spinal Elements, INC. | $39.44 | 2023 | |
| Penumbra, INC. | $26.28 | 2019 | |
| Siemens Medical Solutions USA, INC. | $21.00 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$802,926.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Lauryssen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.